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The infection of epithelial cells by some animal rotavirus strains requires the presence of sialic acid (SA) on the cell
surface. Recently, we isolated rhesus rotavirus variants, named nar, whose infectivity, like that of human rotaviruses, is not
dependent on SA. In this work, we have determined the binding properties of these SA-dependent and -independent rotavirus
strains to MA104 cells. The half-time of attachment of the SA-dependent porcine rotavirus YM and reassortant virus
DS1xRRV was found to be about 10 times longer in neuraminidase-treated cells than in untreated cells. On the other hand,
human rotaviruses Wa and DS1, and the variant nar3, bound to cells two to three times more rapidly in the absence of SA.
To investigate whether the SA-independent cellular structure recognized by the variant and human rotaviruses was the same,
we used an infection assay designed to detect competition for cell surface molecules at both attachment and postattachment
steps. In this assay, human rotavirus Wa efficiently competed the infectivity of YM in untreated cells and that of the variant
nar3 in untreated, as well as neuraminidase-treated, cells. This competition was nonreciprocal, since YM and nar3 did not
compete, but rather increased three- to fivefold the infectivity of Wa. In contrast, a two-direction competition between the
variant nar3 and DS1xRRV was found. Similar results were obtained when psoralen-inactivated viruses were used as
competitors, indicating that the competition observed was during the early stages of infection. Altogether, these results
suggest the existence of multiple interactions between rotaviruses and the cell surface and revealed the existence of
common steps during the entry of human and animal rotavirus strains. © 1999 Academic Press
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Rotaviruses are the single most important cause of
evere dehydrating diarrhea in young children world-
ide. In vivo, the infection by these viruses is highly
estricted to the mature villus tip cells of the small intes-
ine (Kapikian and Chanock, 1996). Rotavirus particles
re formed by three concentric layers of protein; in the
urface of the virus there are two proteins, VP4 and VP7,
hich are responsible for the initial interactions of the
irus with the host cell (Estes, 1996). VP4, which forms
he spikes of the particle (Shaw et al., 1993; Yeager et al.,
994), has been identified as the viral attachment
olypeptide (Bass et al., 1991; Crawford et al., 1994;
udert et al., 1996; Me´ndez et al., 1993; Ruggeri and
reenberg, 1991). This protein is cleaved by trypsin into
ubunits VP5 and VP8, and this cleavage is associated
ith the penetration of the virion into the cell (Espejo et
l., 1981; Estes et al., 1981). VP7 forms the outermost
ayer of the virion and interacts with the base of the VP4
pikes (Shaw et al., 1993; Yeager et al., 1994). Although
he role of VP7 during the early interactions of the virus
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450ith the cell has not been defined, it has been proposed
hat it may modulate the functions of VP4 (Beisner et al.,
998; Me´ndez et al., 1996; Xu and Woode, 1994) and
nteract with cell surface molecules after the initial at-
achment of the virus through the spike protein (Estes,
996; Coulson et al., 1997).
Rotaviruses may have different requirements to infect
A104 cells, a cell line highly susceptible to these vi-
uses. Some rotavirus strains isolated from animals need
ialic acid (SA) residues on the cell surface for infection,
ince their infectivity is severely reduced in neuramini-
ase (NA)-treated cells or by incubation of the virus with
ialoglycoproteins, like glycophorin A (Ciarlet and Estes,
999; Fukudome et al., 1989; Keljo and Smith, 1988;
e´ndez et al., 1993; Yolken et al., 1987). On the other
and, the infectivity of rotaviruses isolated from humans
s not reduced by these treatments (Fukudome et al.,
989). Consistent with these observations, many animal,
ut not human rotavirus (HRV) strains, are able to agglu-
inate red blood cells through the interaction of VP4 with
A on the erythrocyte (Fukudome et al., 1989; Lizano et
l., 1991; Mackow et al., 1989). The hemagglutination
omain of the rhesus rotavirus (RRV) VP4 protein has
een mapped to a region in VP8 between amino acids 93
nd 208 (Fuentes-Panana et al., 1995; Isa et al., 1997),
nd this domain also seems responsible for the interac-
ion of RRV with SA on the surface of epithelial cells,
ince neutralizing monoclonal antibodies (mAbs) to VP8
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451ROTAVIRUS CELL RECEPTORSre able to block the binding of the virus to MA104 cells
Ruggeri and Greenberg, 1991).
We recently described the isolation of RRV variants,
amed nar, which no longer need SA for infection. These
ariants, unlike wild-type (wt) RRV, are not neutralized by
Abs to VP8, despite the fact that they are bound by
hese mAbs as efficiently as the wt virus (Me´ndez et al.,
993). These data suggest that the VP4 domain used by
he variants to attach to the cell surface is different from
he SA-attachment site employed by the parental virus.
RVs also attach to the cell through VP4 (Kirkwood et al.,
998; Ludert et al., 1996); however, the protein domain
nvolved in this interaction has not been determined.
In this work we have characterized the cell attachment
inetics of rotaviruses from animal and human origin and
f SA-independent RRV variants. We also carried out
ompetition infection assays among these strains, to
stablish whether there are shared interactions with cell
urface molecules during cell entry.
RESULTS
nfectivity of rotaviruses in neuraminidase-treated
ells
Simian rotavirus RRV requires SA to attach to, and
nfect, the host cell. We recently isolated variants from
his virus whose cell infection is independent of SA
Me´ndez et al., 1993). The infectivity of variant nar3,
imilar to that of HRV strains DS1 and Wa, is not de-
reased, and actually is somewhat increased, in cells
hat have been previously treated with NA (Fig. 1). In
ontrast, the infectivity of animal rotaviruses RRV and YM
FIG. 1. Infectivity of rotaviruses in neuraminidase-treated MA104
ells. MA104 cells in 96-well plates were treated with the indicated
oncentrations of NA from A. ureafaciens for 1 h at 37°C and subse-
uently infected with approximately 1000 FFU per well of the corre-
ponding virus. Twelve hours postinfection the cells were fixed and
mmunostained with a rabbit anti-rotavirus serum, as described under
aterials and Methods. The infectivity is expressed as the percentage
f FFUs observed in untreated cells infected with the same viruses.s blocked by this treatment. The infectivity of the reas- aortant virus DS1xRRV, with a VP7 protein derived from
he human strains DS1 and a VP4 protein derived from
otavirus RRV, is also affected by the NA treatment
Fig. 1).
nfluence of sialic acids on the attachment rate of
otaviruses
To characterize the attachment kinetics of rotaviruses
o the surface of MA104 cells in the presence or absence
f SA, we developed an indirect, nonradioactive binding
ssay, similar to that described for picornaviruses
Rueckert, 1986). Since the physical to infectious parti-
les ratio for rotaviruses is high (between 1/100 and
/400 for animal rotaviruses like nar3 and YM and be-
ween 1/10,000 and 1/30,000 for the human strain Wa;
ee Materials and Methods), the assay was designed to
easure the binding of infectious rather than physical
articles, in order to detect the biologically relevant vir-
s–cell interactions. These might represent a small frac-
ion of the total interactions and could be obscured in
raditional binding experiments where the attachment of
otal physical particles is measured.
For this assay, trypsin-activated virus, at a multiplicity
f infection (m.o.i.) of less than 0.1, was adsorbed to
onolayers of MA104 cells that had been previously
reated or not with NA. The adsorption step was carried
ut at 4°C for the indicated times, the unbound virus was
emoved, and the cells were then incubated at 37°C for
2 h to allow the bound virus to infect the cell. After this
ime, the cells were fixed and immunostained with a
olyclonal serum to rotavirus, and the virus-infected cells
ere quantitated. The analysis of the time course of
inding showed that the half-time of attachment for por-
ine rotavirus YM, whose infectivity is SA dependent,
as 6 min in untreated cells, while it increased sevenfold
43 min) in NA-treated cells (Fig. 2A, Table 1). Rotavirus
S1xRRV, whose infectivity also depends on the pres-
nce of SA, had a behavior similar to that of YM, with a
alf-time of attachment of 3.5 min in untreated cells
ersus 49 min in cells treated with NA (Fig. 2A, Table 1).
n the other hand, the attachment rate of HRV strains
S1 and Wa did not decrease by the NA treatment of
ells, in agreement with the observation that the infec-
ivity of HRVs does not depend on SA to infect the cells;
n fact, these strains attached two to three times faster to
A-treated cells than to untreated cells (Fig. 2B, Table 1).
he mutant virus nar3 behaved very much like the HRV
trains, attaching twice as fast to NA-treated cells com-
ared to untreated cells (Fig. 2C, Table 1).
ompetition infection assay
Since variant nar3 attached efficiently to cells in the
bsence of SA, as HRVs did, we investigated whether the
A-independent cellular structure recognized by the vari-
nt was the same recognized by the HRV strains. For
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452 ME´NDEZ ET AL.his, we carried out infection competition experiments
etween the variant strain and HRV Wa. We also evalu-
ted the ability of nar3 and Wa viruses to compete with
nimal rotaviruses. As representative SA-dependent
trains we used porcine rotavirus YM and reassortant
irus DS1xRRV. The latter strain was included in the
tudy to widen the spectrum of competitions that could
e carried out, given the limitations of the method (see
elow).
FIG. 2. Binding kinetics of rotaviruses. Trypsin-activated, ice-cold vir
ells in 24-well plates maintained at 4°C. At the indicated times ice-col
ells were transferred to 37°C for 12 h to allow the infection to proceed,
erum. The animal (A), human (B), and SA-independent animal variant
A-treated (1NA) MA104 cells is indicated. The results shown are repThe conventional competition binding assays use a mabeled virus that is adsorbed to the cell in the absence
r presence of a large excess of the unlabeled compet-
tor virus. This type of competition assay measures the
ttachment of physical, not infectious particles, with the
rawbacks described above. In addition, this kind of
ssay detects competition only for the initial event of
ttachment and does not allow the detection of potential
ompetition for interaction with cell surface molecules
hat might be shared by the two viruses tested, but that
m.o.i. of less than 0.1, was added to confluent monolayers of MA104
was added to stop virus binding and the inoculum was washed away.
Us were determined by immunostaining with a polyclonal anti-rotavirus
ains used are indicated in each panel. Binding to untreated (2NA) or
tive of at least two independent experiments performed in duplicate.us, at a
d MEM
and FF
(C) stright occur subsequent to the initial binding. The com-
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453ROTAVIRUS CELL RECEPTORSetition experiments carried out in this work were de-
igned to overcome these two pitfalls, so that we could
etect: (i) the binding of infectious particles, not physical
articles, and (ii) not only primary, but also secondary
irus–cell interaction events. In this assay, the competitor
irus is adsorbed for 1 h at 4°C to a monolayer of MA104
ells. The unbound virus is washed off, and the second
irus (the one to be competed) is incubated at 4°C for 10
in. After the second virus is removed, the cells are
ncubated for 12 h at 37°C, and then the infected cells
re stained with mAbs that are able to discriminate
etween the two viruses used, detecting specifically the
econd virus (see Table 2). The pairs of viruses that
ould be studied with this assay were thus restricted to
he availability of mAbs with these characteristics. The
esults obtained when variant nar3, porcine YM, and
uman Wa rotavirus strains were used as competitor
iruses are as follows:
(i) Variant nar3. The variant virus failed to compete
RV Wa, both in untreated or in NA-treated cells (Figs. 3A
nd 4A) indicating that despite the fact that they both
ind very efficiently to cells in the absence of SA, they do
ot bind to the same cell molecule. In fact, the incubation
f the cells with a large excess of the variant virus
onsistently increased the infectivity of Wa about fivefold,
n a dose-dependent manner. On the other hand, prein-
ubation of untreated cells with variant nar3 blocked by
ore than 99% the infectivity of reassortant rotavirus
S1xRRV (Fig. 3A). The competition of nar3 for YM could
ot be evaluated due to the unavailability of a mAb able
o distinguish between these two strains.
(ii) Rotavirus YM. When YM was used as the compet-
tor strain in untreated MA104 cells, the results were very
imilar to those described for nar3. YM not only did not
ffect the infectivity of Wa, but also reproducibly in-
TABLE 1
Kinetic Binding Constants for Rotaviruses in MA104 Cells
Virus strain
Attachment rate
constants
(cells/ml 3 min)21 Binding t1/2 (min)
Untreated NA-treated Untreated NA-treated
uman
Wa 9.031028 2.431027 38 14.5
DS1 2.531027 6.131027 13.5 5
A-independent
variant
nar3 4.831027 9.231027 15 7.5
A-dependent
YM 9.031027 7.031028 6 43
DS1xRRV 5.731027 8.031028 3.5 49
Note. The attachment rate and binding t1/2 were determined from the
inear regression presented in the graphs of Fig. 2.reased it (Fig. 3B), while it blocked efficiently the infec- sivity of the SA-dependent virus DS1xRRV. Since a mAb to
iscriminate between YM and nar3 was not available, we
sed DS1xRRV as the competitor virus to evaluate the
bility of a SA-dependent strain to compete the infectivity
f the variant. As can be seen in Fig. 3C, this reassortant
fficiently competed the infectivity of nar3, while it also
ncreased the infectivity of Wa. These results suggest
hat in cells from which SA has not been removed,
nimal rotaviruses and the variant interact, either with
he same SA-containing cell receptor or with two mole-
ules that are very close, such that binding of the first
irus (e.g., DS1xRRV) to one of these two putative cell
olecules interferes with the binding of the second virus
e.g., nar3) to the other molecule. Competition experi-
ents using either YM or DS1xRRV were not carried out
n NA-treated cells, since these strains attach very poorly
o cells in the absence of SA.
(iii) Rotavirus Wa. When rotavirus Wa was used as the
ompetitor virus in untreated cells, it inhibited the infec-
ivity of variant nar3 and porcine rotavirus YM, as effi-
iently as that of HRV DS1 (Fig. 3D). In NA-treated cells
t also blocked the infectivity of nar3 and DS1 (Fig. 4B).
ltogether, these results suggest that although YM (as
ell as nar3) first attaches to a cell receptor that is
ifferent from that used by Wa, there should be at least
ne interaction (which can be competed) shared among
hese viruses during entry to MA104 cells.
he decrease or increase in the infectivity of the
econd virus does not depend on replication
f the blocking virus
To rule out the possibility that the competition ob-
erved between some of the viruses tested was at the
ntracellular level, as a result of overloading the cell
achinery with the replication of the competitor virus, we
arried out competition infection assays with viruses that
ad been inactivated with psoralen. Psoralen-treated an-
mal rotaviruses maintain their ability to interact with
Abs directed at the surface proteins and to hemagglu-
inate, i.e., to bind to SA, but these viruses are not able to
eplicate (data not shown, and Groene and Shaw, 1992).
TABLE 2
Monoclonal Antibodies Used to Discriminate Viruses
in the Competition Infection Assay
Competitor virus Second virus mAb useda
mAb
specificity
ar3, YM, or DS1xRRV Wa 631/9 Subgroup II
a DS1, nar3, or YM 255/60 Subgroup I
ar3 or YM DS1xRRV 2F1 1 1C10 Serotype G2
S1xRRV nar3 4F8 1 159 Serotype G3
a These mAbs discriminated between the two competing viruses,
pecifically detecting the second virus.
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454 ME´NDEZ ET AL.Psoralen-treated nar3 virus was as efficient as the
ntreated virus at competing the infectivity of DS1xRRV,
ven when this treatment decreased its infectivity by
000-fold (Fig. 5A). Similarly, psoralen-treated Wa main-
ained the ability to block the infectivity of YM, albeit to a
evel somewhat lower than that caused by the untreated
irus (Fig. 5B). The increase in the infectivity of Wa
nduced by YM was also observed with psoralen-inacti-
ated YM, which had a titer 10,000-fold lower than that of
he control virus (Fig. 5C).
Altogether, these results indicate that the block or
nhancement of infectivity observed in the competition
nfection assay does not depend on the replication of the
ompetitor virus and most likely is the consequence of
nteractions with cell surface molecules.
DISCUSSION
Rotaviruses bind to permissive cells by at least two
echanisms. Some rotaviruses of animal origin attach to
molecule in the cell surface that contains SA. On the
ther hand, rotaviruses of human origin appear to bind to
FIG. 3. Competition infection in MA104 cells. The competitor virus at
or 1 h at 4°C. After the competitor virus was removed, a second virus
old MEM and the plates were transferred to 37°C to allow the infectio
nd immunostained with mAbs specific for the second virus (see Table
f the infectivity of the second virus in the absence of competitor. The
B), DS1xRRV (C), or Wa (D) were used as competitors. The results sho
uplicate.ermissive cells via a SA-independent molecule [this tork and Fukudome et al. (1989); Keljo and Smith (1988);
e´ndez et al. (1993)]. The interaction of animal rotavi-
uses with SA does not seem to be essential, since
ariants that bind to cells in a SA-independent manner
ave been isolated from rhesus rotavirus RRV, a strain
hat depends on SA for cell binding (Ludert et al., 1998;
e´ndez et al., 1993).
In this work, one such RRV variant, nar3, was found to
ttach about twice as fast to cells that have been treated
ith NA, compared to untreated cells. This increased
ate of attachment, which was also observed with the
RV strains, might be responsible for the 20 to 50%
ncrease in infectivity that is consistently observed for
he human and SA-independent RRV variant strains in
A-treated cells (Fig. 1; Fukudome et al., 1989; Me´ndez
t al., 1993), suggesting that SA is masking the asialo
eceptor molecule used by the human and variant
trains. Conversely, the attachment rate of the SA-depen-
ent strains YM and DS1xRRV decreased by 7- to 14-fold
hen SA was removed from the cell surface, in agree-
ent with the marked inhibition of their infectivity under
icated m.o.i. was added to a monolayer of MA104 cells and incubated
ded for 10 min at the same temperature. The cells were washed with
ceed. After 12 h of incubation at this temperature, the cells were fixed
Materials and Methods). The results are expressed as the percentage
be competed is indicated in each panel where viruses nar3 (A), YM
representative of at least two independent experiments performed inthe ind
was ad
n to pro
2, and
virus to
wn arehese conditions (Fig. 1, and Me´ndez et al., 1993).
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455ROTAVIRUS CELL RECEPTORSSince the variants efficiently attach to, and infect,
A104 cells in the absence of SA, as HRVs do, we
nvestigated whether the SA-independent cellular struc-
ure recognized by the variants could be the same as that
sed by HRV strains. For this, we carried out infection
ompetition experiments designed to evaluate competi-
ion of rotavirus strains not only at the level of attach-
ent, but also at postbinding steps. This assay seems
ndeed to detect competitions during the early stages of
nfection, most likely at the cell membrane level, rather
han competition for replication inside the cell, since
soralen-inactivated viruses maintained their ability to
ompete.
In this assay, HRV Wa efficiently blocked the infection
f variant nar3 in both NA-treated and untreated cells;
owever, this competition was in only one direction,
ince the variant virus did not compete the HRV strain.
his finding suggests that these viruses, despite sharing
SA-independent phenotype, bind to different cell recep-
ors.
FIG. 4. Competition infection in neuraminidase-treated MA104 cells.
he experiment was carried out as described in the legend to Fig. 3, but
he cells were pretreated with 40 mU/ml of NA from A. ureafaciens for
h at 37°C before addition of the competitor virus. The results are
xpressed as the percentage of the infectivity of the second virus in the
bsence of competitor. The virus to be competed is indicated in each
anel where viruses nar3 (A) or Wa (B) were used as competitors. The
esults shown are representative of at least two independent experi-
ents performed in duplicate.We have previously shown that despite the fact that she variants do not need SA to infect the cells, they retain
heir ability to agglutinate red blood cells in a SA-depen-
ent manner (Me´ndez et al., 1993). However, apparently
he variants bind to a SA-independent cell surface mol-
cule even in normal, untreated cells, since the attach-
ent of these viruses to untreated cells is blocked by a
Ab directed to the MA104 cell surface, which does not
lock the SA-dependent binding of parental RRV (Lo´pez
t al., manuscript in preparation). These data indicate
hat the site used by the variant virus to attach to the cell
s different from that recognized by the SA-dependent
nimal rotavirus strains. Thus, the reciprocal competition
bserved between the SA-dependent strain DS1xRRV
nd the variant would not appear to be the result of
ompetition for binding to SA, but rather the result of
ompetition for the attachment to two close sites (one of
hem SA, for the binding of DS1xRRV) that might be
ocated either in different molecules or in the same
ellular structure.
Similar to the findings with nar3, two SA-dependent
trains, porcine rotavirus YM and the reassortant virus
S1xRRV, failed to compete the infection of human rota-
irus Wa, while Wa efficiently competed these two
trains. This unidirectional competition, together with the
ifferential requirement for SA of these strains, clearly
ndicates that different molecules are involved in the
ttachment of animal and human rotavirus strains.
The results described above suggest the existence of
t least three cellular structures (which may or may not
e part of the same cell molecule) involved in the infec-
ion of MA104 cells by rotaviruses, with at least one
eing shared by human, animal, and variant strains. We
ypothesize that during the early stages of infection
here are several sequential interactions between rota-
irus and cell surface molecules. In this hypothesis,
nimal rotaviruses first interact with a sialylated receptor,
nd this initial interaction facilitates a second interaction
ith an asialo molecule; we have proposed that the
ariant nar3 is able to interact efficiently with this asialo
olecule, bypassing the interaction with SA (Me´ndez et
l., 1993, 1996; Za´rate et al., submitted for publication).
ere we propose that HRVs bind to a different asialo
tructure in the cell surface, which is used by neither the
nimal nor by the mutant viruses to initially attach to the
ell, but is required by these two types of viruses in a
ubsequent step during infection and may represent a
ommon step during the entry of human, animal, and
ariant rotavirus strains.
It has been described that the interaction of animal
otaviruses with the SA-containing receptor is mediated
y a binding domain in the VP8 subunit of VP4 (Fuentes-
anana et al., 1995; Isa et al., 1997). Recent data from our
aboratory indicate that the initial attachment of the SA-
ndependent RRV variants to the asialo molecule is via
P5, the carboxy-terminal domain of VP4 (Za´rate et al.,
ubmitted for publication). It is also known that HRVs
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456 ME´NDEZ ET AL.ttach to the cell through VP4 (Kirkwood et al., 1998;
udert et al., 1996); however, the protein domain respon-
ible for this interaction has not been characterized. It is
ikely that this binding site is located in VP5, since in
RVs this domain is the main target of neutralizing mAbs
o VP4 (Matsui et al., 1989). Although VP7 has not yet
een assigned a clear role in the interaction of either
uman or animal rotaviruses with the cell surface, it
ould well be involved in late interaction steps, after the
nitial binding of the virus through VP4.
Multiple interactions of viruses with cell surface com-
onents, in several cases involving more than one type
f component, appear to be more frequent than once
hought (Haywood, 1994). The presence of coreceptors
as been shown to be important for several viruses like
uman immunodeficiency virus (Alkhatib et al., 1996;
eng et al., 1996), herpes simplex virus (Geraghty et al.,
998; Montgomery et al., 1996), and adenovirus (Bergel-
on et al., 1997; Wickham et al., 1993), among others.
The preincubation of MA104 cells with porcine rotavi-
us YM or the RRV variant nar3 consistently enhanced
FIG. 5. Competition infection in MA104 cells with psoralen-inactivate
xcept that the competitor virus was previously inactivated by treatm
omparison, the same virus preparation, before inactivation, was also
o the titer of the virus before psoralen inactivation. Equal dilutions of t
o be competed is indicated in each panel where viruses nar3 (A), Wa
ompetitors. The psoralen treatment reduced the virus titer from 2.4 3
ase of Wa, and from 4.5 3 107 to 2.8 3 103 in the case of YM. The
erformed in duplicate.RV Wa infectivity; this enhancement was also observed qhen psoralen-inactivated viruses were used to prein-
ubate the cells. It is possible that the physical particles
infectious plus noninfectious) could trigger a cell re-
ponse that causes the cell to enter into an “activated”
tate that facilitates Wa virus replication. A similar en-
ancement effect has been reported for the duck hepa-
itis B virus, where inactivated subviral particles caused
n increase in the infectivity of the virus, when they were
reincubated with the cells. In this system, the enhance-
ent was dependent on the presence of the viral attach-
ent domain in the inactivated particles (Bruns et al.,
998). Also, it is known that the infectivity of reovirus in
ultured cells is enhanced by an activated Ras signaling
athway (Strong et al., 1998), and this pathway could be
ctivated by the interaction of the virus with the epider-
al growth factor receptor. Similarly, the interaction of
M or nar3 rotaviruses with the cell surface could acti-
ate a signaling pathway that may facilitate the cell
nfection of HRV Wa.
Integrins have been recently implicated as rotavirus
eceptors, since VP4 and VP7 have integrin ligand se-
. The experiment was carried out as described in the legend to Fig. 3,
ith 40 mg/ml of psoralen and exposure to UV light for 30 min. For
the competitions. The m.o.i. indicated for the competitor virus refers
ralen-treated virus, compared to untreated virus, were used. The virus
d YM (C), treated (1pso) or not (2pso) with psoralen, were used as
.8 3 104 FFU/ml in the case of nar3, from 1.3 3 107 to 1.2 3 105 in the
shown are representative of at least two independent experimentsd virus
ent w
used in
he pso
(B), an
107 to 1
resultsuences, and mAbs to integrins a2b1, a4b1, and axb2
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457ROTAVIRUS CELL RECEPTORSartially block the infectivity of HRV RV5 as well as that of
imian rotavirus SA11 (Coulson et al., 1997). However, no
irect binding of the viruses to these molecules was
chieved, and the pattern of expression of these inte-
rins does not appear to explain by itself the tropism of
otavirus for the mature enterocyte (Coulson et al., 1997).
hese data, together with the results presented here,
uggest that other cell molecules could be involved in
he initial interactions of rotavirus with the host cell,
hich could contribute to the high selective tropism of
hese viruses. Asialo- and sialo-glycolipids, as well as
lycoproteins, have been shown to bind to animal rota-
iruses and they have also been proposed as possible
otavirus receptors (Bass et al., 1991; Rolsma et al., 1998;
rnka et al., 1992; Superti and Donelli, 1991; Willoughby
t al., 1990). Further experiments are needed to deter-
ine the role of the various interactions described, as
ell as of others yet to be identified, in a rotavirus cell
ntry process that seems far more complex than antici-
ated.
MATERIALS AND METHODS
iruses, cells, and monoclonal antibodies
Rotavirus strains Wa, DS1, and RRV and the reassor-
ant virus DS1xRRV were obtained from Dr. Harry B.
reenberg, Stanford University, Stanford, California. Re-
ssortant DS1xRRV has the VP7 gene derived from DS1
nd most other genes, including the gene encoding VP4,
erived from rhesus rotavirus RRV (Me´ndez et al., 1993).
he SA-independent rotavirus RRV variant nar3 (Me´ndez
t al., 1993; Me´ndez et al., 1996) and the porcine rotavirus
M (Ruiz et al., 1988) have been previously described. All
otavirus strains were propagated in MA104 cells as
escribed previously (Espejo et al., 1980). The rhesus
onkey epithelial cell line MA104 was grown in Eagle’s
inimal essential medium (MEM) supplemented with
0% fetal bovine serum and was used for all experiments
arried out in this work.
Monoclonal antibodies mAbs 631/9 (subgroup II-spe-
ific), 255/60 (subgroup I-specific), 2F1 and 1C10 (type
2-specific), and 4F8 and 159 (type G3-specific) were
indly provided by Dr. Harry B. Greenberg, Stanford Uni-
ersity.
euraminidase treatment of cells
Monolayers of MA104 cells in 96-well plates were
reated with the indicated amounts of Arthrobacter ure-
faciens neuraminidase (NA) for 1 h at 37°C, as previ-
usly described (Me´ndez et al., 1993).
irus binding assay
The binding assay was carried out at 4°C on MA104
ell monolayers grown in 24-well plates. Cells were
ashed twice with cold PBS, and the plates were kept on rce. Two hundred microliters of cold, trypsin-activated
irus (30 min at 37°C with 10 mg/ml trypsin) was added
o the cells (at less than 0.1 focus-forming units (FFU)/
ell) and adsorbed at 4°C for various times. After the
dsorption step, the virus inoculum was diluted to stop
inding, the unbound virus was removed, and the cells
ere washed twice with cold MEM and incubated for
2 h at 37°C. The cells were fixed with 80% acetone in
BS and immunostained with a rabbit polyclonal anti-
otavirus serum, as described (Lizano et al., 1991). When
inding experiments were carried out in NA-treated
ells, these were treated with 40 mU/ml of NA as de-
cribed above and washed twice with cold MEM before
se. Virus binding was estimated as function of the
umber of infected cells detected. The number of in-
ected cells was proportional to the time of adsorption of
he virus in the time range studied. Binding was temper-
ture-independent since the same viral titer was found
hen the virus was attached at either 4 or 37°C.
stimation of the attachment rate constant and
alf-time of attachment
The assay was carried out with a large excess of
eceptor over the amount of virus; thus, this interaction
as considered as a first-order reaction governed by the
quation (Rueckert, 1986)
In (Vo /V t 5 (KC) t,
here Vo is the total amount of infectious virus particles
dded to 2 3 105 cells (C), and V t is the unattached virus
n a period of time (t). K represents the attachment rate
onstant for formation of virus–cell complexes. This con-
tant was calculated for each virus from the slope (m 5
C) of the linear regression curves. For this analysis, it
as assumed that the binding sites on the virus and on
he cell were unique and homogeneous. The unattached
nfectious virus at a given time was calculated as the
otal infectious virus added minus the number of infected
ells. As a first-order reaction, the half-time of attach-
ent was calculated by the equation
t1/2 5 0.693/k,
here k is the product KC and represents the slope of
he curves in Fig. 2.
ompetition infection assay
The assay was carried out at 4°C on monolayers of
A104 cells grown in 96-well plates. The plates were
ept on ice during the course of the experiment until they
ere transferred to 37°C to allow the viruses to infect the
ells. To prepare the competitor virus (activated with
rypsin as described above) an infected cell lysate was
xtracted with freon, and the virus was pelleted at 25,000pm in a SW28 rotor (Beckman) for 2 h at 4°C and finally
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458 ME´NDEZ ET AL.esuspended into MEM in about 1/20 to 1/40 of the initial
olume. For the assay, the first, competitor virus was first
dsorbed for 1 h at different m.o.i.s to cells previously
ashed twice with PBS. The excess, unbound virus was
emoved, and the cells were washed once with cold
EM. Serial twofold dilutions of the trypsin-activated
econd virus (the one to be competed) were then ad-
orbed for 10 min to these cells. The unadsorbed second
irus was removed, and the cells were then washed
wice with cold MEM and transferred to 37°C to allow the
irus infection to proceed. Twelve hours later, the cells
ere immunostained with mAbs specific for the second
irus (see Table 2), which were shown not to cross-react
ith the competitor virus at the m.o.i.s employed. After
mmunostaining, the titer of the second virus in the pres-
nce of the competitor virus was determined, and it was
xpressed as the percentage infectivity compared to the
iter obtained in the absence of competitor. Cells infected
eparately with either of the two viruses and stained with
polyclonal anti-rotavirus antibody were used as con-
rols to confirm the m.o.i. of the competitor virus as well
s the titer of the second virus in the absence of com-
etitor. When competition experiments were carried out
n NA-treated cells, these were treated with 40 mU/ml of
. ureafaciens NA as described above.
soralen inactivation
The inactivation of rotaviruses with psoralen was car-
ied out essentially as described (Groene and Shaw,
992). To determine the optimum conditions for virus
nactivation, a lysate of cells infected with rotavirus YM
clarified at 800g for 5 min) was treated with psoralen at
ifferent concentrations (0, 5, 10, 20, 30, and 40 mg/ml;
tock of 1 mg/ml in 50% ethanol). Virus–psoralen mix-
ures were kept on ice for 15 min and then exposed to UV
ight (366 nm) for different times. The best level of inac-
ivation (a reduction of 3 to 5 orders of magnitude in virus
iter) was obtained with 40 mg/ml of psoralen and 30 min
f UV light. These conditions were used for inactivating
ll rotavirus strains; the degree of inactivation achieved
as determined in each case. The hemagglutination
iter, for the hemagglutinating strains, was not affected
y the psoralen treatment. In the experiments where
hese inactivated viruses were used, the m.o.i. refers to
he titer of the virus before treatment.
stimation of physical particles
To have an estimate of the infectious to physical par-
icles ratio for the different virus strains used, we deter-
ined the rotavirus dsRNA concentration in the clarified
irus-infected cell lysates and calculated the number of
hysical particles assuming that 1 mg of viral dsRNA is
quivalent to 5 3 1010 virus genomes and therefore to an
quivalent number of virus particles. The number of the
hysical particles calculated in this way was then relatedo the FFU titer of the lysate, as determined by an immu-
operoxidase assay (Lizano et al., 1991). The calculated
nfectious/physical particles ratio ranged from 1/100 to
/400 for the various lysates of rotavirus nar3, DS1xRRV,
nd YM used and from 1/10,000 to 1/30,000 for Wa.
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